Training programs to improve cancer care decision-making
Official title: Methods Training for Comparative Effectiveness Research in Cancer
Funded at University of Tx Md Anderson Can Ctr · NIH-10932944 · Data updated 2026-11-12
This study is creating a training program for new cancer researchers to help them learn how to compare different cancer treatments using real-world evidence, so they can better understand what works best for all patients, including those from diverse backgrounds.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 21, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $316,225 |
| NIH project number | 5R25CA278726-02 |
| Project ID | NIH-10932944 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are junior cancer investigators and healthcare professionals involved in cancer treatment and care.
✕Less likely to help
Patients who are not involved in cancer research or treatment decision-making may not receive direct benefits from this research.
What this research studies
This research focuses on developing a national training program for junior cancer investigators to enhance their skills in comparative effectiveness research (CER). By emphasizing real-world evidence, the program aims to equip researchers with the methodologies needed to evaluate and compare various cancer treatments beyond traditional clinical trials. This approach addresses the limitations of existing studies that often exclude diverse patient populations, ensuring that findings are more applicable to everyday healthcare settings. Participants will learn how to assess the benefits and harms of multiple cancer therapies, ultimately improving patient care.
Why it matters
Potential benefit: If successful, this research could lead to better-informed healthcare decisions and improved cancer treatment options for patients.
How similar studies have gone: Previous research in comparative effectiveness has shown promise in improving treatment outcomes, indicating that this approach is both relevant and necessary.
Where this research is happening
-
University of Tx Md Anderson Can Ctr
Houston, United States Active
Researchers
- Principal investigator: Suarez-Almazor, Maria E — University of Tx Md Anderson Can Ctr
- Study coordinator: Suarez-Almazor, Maria E
Related research
Other NIH-funded projects on the same topics.
-
HIV-related cervical cancer screening and care in LMICs (AVANÇO HAMRC)
A multi-country effort to build sustainable research infrastructure and low-cost cervical cancer screening and treatment methods for women living with HIV in Brazil and Mozambique.
-
HIV-associated cervical cancer care infrastructure in LMICs
A program to build sustainable research infrastructure and bring low-cost cervical cancer screening, diagnosis, and treatment to women with HIV in Brazil and Mozambique.
-
HIV-associated cervical cancer screening and care network in LMICs
A multinational program aims to build affordable, practical cervical cancer screening, diagnosis, and treatment methods for women living with HIV in Brazil and Mozambique.
-
Mapping HIV-like SIV Reservoirs in the Brain with Advanced PET Imaging
This project develops brain-targeted imaging probes to map SIV reservoirs in the central nervous system of infected macaques, aiming to improve our understanding of how HIV-like viruses hide in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Germline clues to skin-related immune side effects from cancer immunotherapy
This grant looks for genetic clues in people treated with immune checkpoint inhibitors to understand why some develop skin-related immune side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.